Shin Nippon Biomedical Laboratories, Ltd.
Important Dates
Shin Nippon Biomedical Laboratories, Ltd.'s next confirmed earnings release is scheduled for November 10, 2026.
| Earnings Date | 11/10/2026 |
Share Statistics
As of March 31, 2026, Shin Nippon Biomedical Laboratories, Ltd. has 41.63M shares outstanding.
| Shares Outstanding | 41.63M |
Financial Position
As of March 31, 2026, Shin Nippon Biomedical Laboratories, Ltd. maintains a current ratio of 1.09, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.09 |
| Quick Ratio | 0.47 |
| Debt / Equity | 94.87 |
Financial Efficiency
These figures cover the twelve months ended March 31, 2026.
| Employee Count | 1,457.50 |
Stock Price Statistics
EURThese figures are as of the close on October 22, 2026.
| 50-Day Moving Average | 7.68 |
Balance Sheet
EURAs of March 31, 2026, Shin Nippon Biomedical Laboratories, Ltd. holds 101.05M in cash and equivalents against 224.93M in total debt, resulting in a net debt position of 121.33M. Total book value stands at 235.08M, with working capital of 19.97M providing operational flexibility.
| Cash & Cash Equivalents | 101.05M |
| Total Debt | 224.93M |
| Net Debt | 121.33M |
| Equity (Book Value) | 235.08M |
| Book Value Per Share | 5.65 |
| Working Capital | 19.97M |
Stock Splits
Shin Nippon Biomedical Laboratories, Ltd.'s most recent stock split took place on September 27, 2005 with a 1:2 split ratio.
| Last Split Date | 9/27/2005 |
| Split Ratio | 1:2 |